GSK plc Reports Share Transaction in 6-K Filing
Ticker: GSK · Form: 6-K · Filed: 2026-04-10T06:51:26-04:00
Sentiment: neutral
Topics: share-transaction, sec-filing, 6-k
TL;DR
GSK plc filed a 6-K on 4/10/26 about a share transaction.
AI Summary
On April 10, 2026, GSK plc filed a Form 6-K with the SEC, reporting a transaction involving its own shares. The filing details a transaction in its own shares, with the report period ending on the same date. The company's mailing and business address is 79 New Oxford Street, London, United Kingdom.
Why It Matters
This filing indicates GSK plc is actively managing its share capital, which could signal changes in its financial strategy or market presence.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a share transaction and does not contain information suggesting significant immediate risk.
Key Players & Entities
- GSK plc (company) — Filer of the 6-K report
- 0001131399 (company) — CIK number for GSK plc
- 2026-04-10 (date) — Filing date and period of report
- 79 New Oxford Street, London, United Kingdom (location) — Mailing and business address of GSK plc
FAQ
What type of transaction did GSK plc report on April 10, 2026?
GSK plc reported a 'TRANSACTION IN OWN SHARES' on April 10, 2026.
What is the CIK number for GSK plc?
The CIK number for GSK plc is 0001131399.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is April 10, 2026.
Where is GSK plc's business address listed in the filing?
GSK plc's business address is listed as 79 New Oxford Street, London, United Kingdom.
What is the accession number for this SEC filing?
The accession number for this SEC filing is 0001654954-26-003393.
From the Filing
EDGAR Filing Documents for 0001654954-26-003393 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001654954-26-003393 Filing Date 2026-04-10 Accepted 2026-04-10 06:51:26 Documents 1 Period of Report 2026-04-10 Document Format Files Seq Description Document Type Size 1 TRANSACTION IN OWN SHARES a8989z.htm 6-K 3659320 Complete submission text file 0001654954-26-003393.txt 3660575 Mailing Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG Business Address 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG 44 20 8047 5000 GSK plc (Filer) CIK : 0001131399 (see all company filings) EIN. : 000000000 | State of Incorp.: X0 Type: 6-K | Act: 34 | File No.: 001-15170 | Film No.: 26853120 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)